About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 188 record(s)
Req # A-2019-001240
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 19-116220-365.Organization: Health Canada
November 2021
Req # A-2019-001357
Adverse Drug Reactions (ADRs) for PANTOPRAZOLE MAGNESIUM. Report numbers: 000723539, 000723979, 000726450, 000726637, 000727399, 000728348, 000730131, E2B_02434316, E2B_02446272, E2B_02472710, E2B_02599182, E2B_02672458, E2B_02672941, E2B_02685154, E2B_02700160.Organization: Health Canada
November 2021
Req # A-2019-001373
Briefing note and/or briefing materials in the Ministerial Executive Correspondence System (MECS) for the following file: 19-116220-365.Organization: Health Canada
November 2021
Req # A-2019-002010
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-101070-56, National Nutritious Food Basket Canada.Organization: Health Canada
November 2021
Req # A-2020-000002
Adverse Drug Reactions (ADRs) for CLOPIDOGREL BISULFATE. Report numbers: E2B_02499226, E2B_02509973, E2B_02525816, E2B_02536420, E2B_02638026.Organization: Health Canada
November 2021
Req # A-2020-000287
Adverse Drug Reactions (ADRs) for Cipralex. Report numbers: E2B_02816765, E2B_02868948, E2B_02865108, 000732950, E2B_02981227, E2B_02932101, 000735168, E2B_02947778. ADRs for Celexa. Report numbers: E2B_02842438, E2B_02860828, E2B_02871928, E2B_02843045, 000733873 E2B_02924306, E2B_02937423, E2B_02937238, E2B_02953593. ADR for Clopixol. Report number: E2B_02836885. ADRs for Trintellix. Report numbers: 000732890, 000733884, E2B_02833072, E2B_02825174, 000733943, E2B_02890728.Organization: Health Canada
November 2021
Req # A-2020-000789
Adverse Drug Reactions (ADRs). Report numbers: 000732078, E2B_03070432, E2B_02378519, E2B_02378543, E2B_03018901, E2B_03048000, E2B_03205313.Organization: Health Canada
November 2021
Req # A-2020-001037
Adverse Drug Reactions (ADRs). Report numbers: 000722381, 000722382, 000722383, 000722386, 000722410, 000722413, 000722415, 000722416, 000722417, 000722418, 000722421, 000722422, 000722424, 000722425, 000722427, 000722428, 000722429, 000722433, 000722434, 000722435.Organization: Health Canada
November 2021
Req # A-2020-001046
Adverse Drug Reactions (ADRs). Report numbers: 000725851, 000725863, 000725876, 000725948, 000725949, 000725957, 000725989, 000725995, 000725996, 000725999, 000726006, 000726007, 000726028, 000726088, 000726097, 000726101, 000726104, 000726116, 000726133, 000726160.Organization: Health Canada
November 2021
Req # A-2020-001125
Adverse Drug Reactions (ADRs). Report numbers: E2B_02541604, E2B_02541629, E2B_02541599, E2B_02855823.Organization: Health Canada
November 2021